Following the screening, Jim Endersby, Ph.D., Professor of the History of Science at the University of Sussex, and moderator Robert J. Howell, Ph.D., Yasser El-Sayed Professor and Chair of the ...
Phase I trials often represent the first occasion where new cancer strategies are tested in patients. Various developments in cancer biology, methodology, regulation, and medical ethics have altered ...
In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...
Cell and Gene Therapy (CGT) has the potential to transform the life trajectory of children with genetic conditions amendable to gene modification with advances in treatment and possible cures. Many of ...
The second half of 2022 brought the first gene therapies for hemophilia to the market in both the United States and abroad. The second half of 2022 brought the first gene therapies for hemophilia to ...
Remote technology has quickly become a critical element of clinical trials. According to a June 2021 survey from WCG, 94% of research sites expect to use at least one form of remote technology in the ...
Speakers at the European Respiratory Society Congress 2024 highlighted the potential of artificial intelligence (AI) in transforming respiratory health care, while also raising important ethical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback